HonorStocks Biotech Gold Oil Mining China Asian MENU
Biotech Gold Oil Mining China Asian
Find Tomorrow's Winners Today

Stock technical analysis
Rating Flag Rating Flag Rating Flag Rating Flag Rating Flag
sell neutral buy
Onconova Therapeutics, Inc. (ONTX)
1.06  -0.04  (-3.64%) 08-13 02:27
Open: 1.1 High: 1.1
Pre.close: 1.1 Low: 0.9862
Volume: 9,746,362 Ave vol: 16,351,634
52w High: 2.84 52w Low: 0.1
MA(50): 0.868 MA(200): 0.519
EPS: -0.358 P/E Ratio: 0
Company profile
Exchange: NASDAQ
Sector: Healthcare
Industry: Biotechnology
Website: http://www.onconova.com
Market Cap (M): 185
Shares Out (M): 174
Onconova Therapeutics, Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing small molecule product candidates to treat cancer. Its product candidates include Rigosertib IV, which is in Phase III clinical trial for patients with higher risk myelodysplastic syndromes (MDS); Rigosertib oral in combination with azacitidine that is in Phase II clinical trial for patients with higher-risk MDS; and Rigosertib oral, which is in Phase II clinical trial for patients with lower risk MDS. The company also develops Briciclib, which is in Phase I multi-site dose-escalation trial for patients with advanced solid tumors; and Recilisib that has completed four Phase I clinical trials for patients with acute radiation syndromes. The company has a license agreement with SymBio Pharmaceuticals Limited; a license, development, and commercialization agreement with Pint International SA; and a license and collaboration agreement with HanX Biopharmaceuticals, Inc.
Technical analysis
Overall: Underperform
MA: Bullish MACD: Bearish
KDJ: Bearish RSI: Bearish
Target 1: 1.82 Target 2: 2.13
Resist 1: 1.56 Resist 2: 1.82
Support 1: 0.93 Support 2: 0.54
Company key metrics
Revenue per Share: 0.0136
Net Income per Share: -0.1341
Cash per Share: 0.1417
Book Value per Share: 0.0722
Price to Sales: 26.4428
Price to Book Value: 4.9874
Earnings Yield: -0.3725
Dividend Yield: 0
Debt to Equity: 1.0454
Debt to Assets: 0.5111
Financial analysis
Price to Book Value: Outperform
Return on Assets: Underperform
Return on Equity: Underperform
Discounted cash flow: Outperform
Price to Earnings: Underperform
Debt to Equity: Outperform
Stock Charts
Headline news
Wed, 12 Aug 2020
Onconova Therapeutics Highlights Corporate Progress and Reports Second Quarter 2020 Financial Results - GlobeNewswire

Wed, 12 Aug 2020
Onconova Therapeutics, Inc. (ONTX) Chart Is Flashing Mixed Signals - The News Heater

Fri, 07 Aug 2020
Onconova Therapeutics to Provide Corporate Update and Second Quarter 2020 Earnings on August 12, 2020 - GlobeNewswire

Tue, 04 Aug 2020
Onconova Therapeutics Announces Compliance with Nasdaq Bid Price Requirement - GlobeNewswire

Mon, 03 Aug 2020
Onconova (ONTX) to Report Q2 Earnings: What's in the Offing? - Yahoo Finance

Fri, 31 Jul 2020
Onconova Therapeutics Inc. NASDAQ:ONTX) Has Submitted an Application with the NIAID for Funding Of Human Studies with Rigosertib in COVID-19 Disease Patients - BP Journal

HonorStocks, Find Tomorrow's Winners Today

©HonorStocks.com | U.S. stock markets, stock quotes and stock analysis. Data and information is provided for informational purposes only, is not intended for trading purposes and is not investment advice. Neither HonorStocks.com nor its data provider shall be liable for any errors or delays in the content, or for any actions taken in reliance thereon. Market data provided by: IEX and Financial Modeling Prep

Privacy Policy: Third parties, including Google, may be placing and reading cookies on your browsers, or other methods to collect information as a result of ad serving on this website. Google's use of advertising cookies enables it and its partners to serve ads to you based on your visit to this site and/or other sites on the Internet. You may opt out of personalized advertising by visiting Ads Settings. If you choose to use this website, you agree to the collection and use of information in relation to this policy. The information collected is used for providing and improving the ads Service. We will not use or share information with anyone, and we do not store any data from users.